Arrhythmia Research Technology Inc.’s quarterly net loss widened to $2.89 million, or $1.06 per share, from $1.04 million, or 37 cents, in the same quarter last year. But the Fitchburg company’s total consolidated revenue from continuing operations grew 1.8 percent, to $4.88 million, from a year before. The company and its Micron Products subsidiary supply products for the medical and defense industries, including software to detect certain heart arrhythmias.
Arrhythmia’s quarterly loss widens
You've reached the limit of 10 free articles a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than $1 a week